Bio-Techne TECH Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Diagnostics And Spatial Biology | $346.26M+6.1% | $326.39M+11.5% | $292.6M— | —— | |
| Protein Sciences | $870.24M+4.7% | $830.9M+28.3% | $647.8M-22.2% | $832.31M+18.1% | |
| Operating Income by Business | |||||
| Diagnostics And Spatial Biology | $21.32M-13.1% | $24.54M-43.0% | $43.04M— | —— | |
| Protein Sciences | $370.35M+4.4% | $354.77M-5.1% | $373.68M-1.0% | $377.62M+14.4% | |
| Selling General And Administrative Expense by Business | |||||
| Diagnostics And Spatial Biology | $136.1M+7.1% | $127.13M+24.9% | $101.81M— | —— | |
| Protein Sciences | $229.06M+5.4% | $217.24M+6.2% | $204.48M— | —— | |
| Cost of Goods Sold by Business | |||||
| Diagnostics And Spatial Biology | $147.95M+9.6% | $134.96M+18.9% | $113.52M— | —— | |
| Protein Sciences | $212.23M+5.1% | $201.98M-3.5% | $209.33M— | —— | |
| Restructuring Charges by Business | |||||
| Corporate | $1.1M— | —— | —— | —— | |
| Diagnostics And Spatial Biology | $83.1M— | —— | —— | —— | |
| Protein Sciences | $13.4M+6,599% | $200K— | —— | —— | |
| Research And Development Expense Excluding Acquired In Process Cost by Business | |||||
| Diagnostics And Spatial Biology | $40.89M+2.9% | $39.75M+16.1% | $34.24M— | —— | |
| Protein Sciences | $58.61M+3.0% | $56.91M-2.3% | $58.25M— | —— | |
| Goodwill by Business | |||||
| Diagnostics And Spatial Biology | $2.2B— | —— | —— | —— | |
| Protein Sciences | $1.69B-0.2% | $1.7B+0.1% | $1.7B+10.6% | $1.53B0.0% | |
| Goodwill Foreign Currency Translation Gain Loss by Business | |||||
| Diagnostics And Spatial Biology | $9.43M+923% | -$1.15M— | —— | —— | |
| Protein Sciences | $3.33M+253% | -$2.18M— | —— | —— | |
| Revenue by Product | |||||
| Consumables | $972.29M+4.8% | $928.18M+1.1% | $917.73M+3.0% | $890.87M+18.5% | |
| Instruments | $112.09M+3.5% | $108.27M-3.4% | $112.09M-7.2% | $120.76M+28.8% | |
| Royalty | $23.69M+1.5% | $23.35M+10.6% | $21.1M-4.0% | $21.98M+16.6% | |
| Service | $111.57M+12.4% | $99.27M+15.7% | $85.78M+19.2% | $71.99M+8.4% | |
| Revenue by Geography | |||||
| APAC Excluding Greater China | $77.26M+4.5% | $73.91M+1.0% | $73.19M-3.9% | $76.14M+10.3% | |
| CN | $100.46M+1.0% | $99.47M-12.6% | $113.87M+1.3% | $112.44M+28.4% | |
| EMEA Excluding UK | $266.31M+10.3% | $241.44M+9.6% | $220.23M+0.5% | $219.06M+69.1% | |
| GB | $54.83M+9.6% | $50.01M+1.1% | $49.46M+1.7% | $48.64M-57.9% | |
| Rest Of World | $37.55M+2.9% | $36.5M-2.7% | $37.49M+6.4% | $35.22M+29.6% | |
| US | $683.23M+3.9% | $657.75M+2.4% | $642.47M+4.6% | $614.11M+22.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bio-Techne break its business down?
- Bio-Techne (TECH) reports revenue by business across 2 parts — Diagnostics And Spatial Biology and Protein Sciences. Each is extracted from the segment footnotes and tracked over time.
- Where does Bio-Techne's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bio-Techne's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
